Oct 18 |
The Zacks Analyst Blog Highlights AbbVie, Automatic Data Processing, Analog Devices, Taylor Devices and Village Super Market
|
Oct 18 |
AbbVie price target raised to $220 from $214 at BMO Capital
|
Oct 18 |
AbbVie Secures FDA Approval for Parkinson's Disease Drug Vyalev
|
Oct 18 |
AbbVie’s Vyalev approved by FDA in advanced Parkinson’s disease
|
Oct 18 |
3 Growth Stocks That Could Be Bargain Buys Right Now
|
Oct 18 |
FDA approves AbbVie’s VYALEV for advanced Parkinson’s treatment
|
Oct 18 |
Jim Cramer Says AbbVie Inc. (ABBV) ‘Is Doing Very, Very Well’
|
Oct 17 |
AbbVie (ABBV) Falls More Steeply Than Broader Market: What Investors Need to Know
|
Oct 17 |
Top Stock Reports for AbbVie, ADP & Analog Devices
|
Oct 17 |
FDA Approves AbbVie's Parkinson's Treatment, Medicare Coverage Expected Next Year
|